What's more, it addresses the FDA’s communications Using the applicant, the retention of information that guidance the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer ownership of an SE report back to a whole new applicant and Digital submission with the SE re